Study Finds No Negative Impact on Children From Anti-Seizure Medications During Pregnancy

**A recent study, funded by the National Institutes of Health (NIH) and published in JAMA Neurology, explored the impact of anti-seizure medications on children born to mothers with epilepsy.** The research focused on the neurodevelopmental outcomes of 387 children, with 298 exposed to anti-seizure medications in utero, predominantly lamotrigine and levetiracetam. Results indicated no significant differences in language abilities at age 6 between children exposed to these medications and those who were not. The study is part of the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD) project, which tracked children from birth to age 6, assessing cognitive functions such as vocabulary and matching spoken words to pictures. According to Kimford Meador, M.D., these tests are more predictive of adult cognitive ability than those performed at younger ages. Treating epilepsy during pregnancy is delicate, as older drugs like valproate are known for causing severe birth defects and lowering IQ. Newer medications seem safer, but whether they affect cognition after fetal exposure remained largely unknown until this study. High doses of levetiracetam were previously linked to poorer cognitive outcomes at age 2 and 3, although overall outcomes were positive. Moreover, the study also revealed beneficial effects of folate during pregnancy, improving cognitive and behavioral outcomes even at higher doses, challenging prior findings of long-term risks with high folic acid intake. Despite positive results, researchers emphasize the need for more studies to understand risks associated with high-dose folate and newer anti-seizure drugs. **The research underscores a delicate balance in epilepsy treatment during pregnancy, ensuring maternal and fetal protection without risking the child's development.** The study was conducted across 20 medical centers in the U.S., led by Dr. Meador and Page Pennell, M.D., contributing valuable insights into prenatal care for women with epilepsy.